Clinical Trial

A Study to Evaluate the Effects of a Fiber Supplement on Gut Health

Completed
View on ClinicalTrials.gov →
Summary
This is a randomized, triple-blind, placebo-controlled clinical trial evaluating the effects of BelliWelli Daily Fiber + Probiotics supplement on gut health over 12 weeks. One hundred participants with self-reported gut health issues will be randomized to receive either the active fiber supplement or a matched placebo product, taken twice daily. Participants will complete questionnaires and provide waist and body composition measurements at Baseline, Week 4, Week 8, and Week 12. The primary outcomes include changes in overall gut health scores, waist circumference, and body composition. Secondary outcomes include participant-perceived effects on bloating, regularity, hydration, energy, and hair, skin, and nail support.
Trial Details
NCT Number NCT07755735
Lead Sponsor Belli Welli Inc.
Collaborators: Citruslabs
Conditions Gut Health, Bloating, Irregular Bowel Movements, Gastrointestinal Symptoms
Enrollment 50 participants
Start Date 2025-08-26
Primary Completion 2026-01-12 (estimated)
Study Completion 2026-01-12 (estimated)
Updated on ClinicalTrials.gov 2026-08-10